NCT03491111

Brief Summary

Stroke survivors commonly have respiratory muscle weakness, swallowing disturbance, general weakness, reduced the daily living activities and short of motivation for rehabilitation. Respiratory muscle training (RMT) has been reported to improve the pulmonary function, respiratory muscle strength, exercise capacity, sensation of dyspnea and quality of life in several diseases, but rare in stroke patients. Reviewing previous reports, the protocol, intensity and duration of respiratory muscle training is still variable. Purpose: To investigate the feasibility and efficacy of respiratory muscle training on cardio-pulmonary function, swallowing function, cough function and reduction of incidence of pneumonia in post-stroke patients. Methods: A prospective, single blinded, randomized study. Consecutive patients with diagnosis of stroke will be proved by magnetic resonance image or computerized tomography. Stroke patients, aged 35-80 years old, with inspiratory muscle weakness or swallowing disturbance will be enrolled and randomly divided into control group (usual rehabilitation alone) and experimental group \[inspiratory muscle training (IMT) group for patients with inspiratory muscle weakness and expiratory muscle strengthening training (EMT) for patients with swallowing disturbance\]. Each patients will receive usual rehabilitation. The investigator expect that RMT will be practical for the restoration of respiratory muscle, swallowing function, cough function and voice quality, thereby reduction of the incidence of pneumonia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

January 30, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 9, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2018

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2018

Completed
Last Updated

December 1, 2020

Status Verified

November 1, 2020

Enrollment Period

2.3 years

First QC Date

January 30, 2018

Last Update Submit

November 29, 2020

Conditions

Keywords

Cerebrovascular diseaserespiratory muscle trainingspirometrypeak flowmaximal inspiratory pressure, maximal expiratory pressure

Outcome Measures

Primary Outcomes (2)

  • MIP (maximal inspiratory pressure)

    MIP(cm H20) is measured after maximal expiration while patients sitting and wearing a nose-clip. For MIP, more negative pressure is better.

    At the beginning and the end of program respectively, up to 6 weeks.

  • MEP (maximal expiratory pressure)

    MEP(cm H20) is measured after maximal inspiration while patients sitting and wearing a nose-clip. For MEP, more positive is better.

    At the beginning and the end of program respectively, up to 6 weeks.

Secondary Outcomes (10)

  • Forced vital capacity, FVC(liter)

    At the beginning and the end of program respectively, up to 6 weeks.

  • Forced vital capacity, FVC(%pred)(liter)

    At the beginning and the end of program respectively, up to 6 weeks.

  • Forced expiratory volume 1/Forced vital capacity, FEV1/FVC(%)

    At the beginning and the end of program respectively, up to 6 weeks.

  • Maximal mid-expiratory flow, MMEF(%)

    At the beginning and the end of program respectively, up to 6 weeks.

  • Peak cough flow(liter/min)

    At the beginning and the end of program respectively, up to 6 weeks.

  • +5 more secondary outcomes

Study Arms (3)

IMT & EMT

EXPERIMENTAL

Interventions: Respiratory muscle training for EMT+IMT. Respiratory muscle training for IMT (Inspiratory muscle training)+EMT (Expiratory muscle training). Respiratory muscle breathing training for patients with inspiratory muscle weakness and swallowing disturbance (MIP less than 70% of normal range).

Other: Respiratory muscle training for EMT+IMTOther: Regular Rehabilitation

Control group

ACTIVE COMPARATOR

Intervention: Non-training group, receive regular rehabilitation. All participants will receive usual rehabilitation care including body positioning instruction, postural correction, breathing control, cough maneuver, respiratory muscle stretch, chest wall mobility exercise and ventilation, fatigue management.

Other: Regular Rehabilitation

EMT group

EXPERIMENTAL

Intervention: Respiratory muscle training for EMT. Respiratory muscle breathing training for swallowing disturbance. EMT for patients with swallowing disturbance will commence from 15% to 75% of threshold load of an individual's MEP.

Other: Regular RehabilitationOther: Respiratory muscle training for EMT

Interventions

2 times per day and 5 day per week, 6 weeks, training with breathing trainer.

IMT & EMT

Regular Rehabilitation: 2-3 times a week, 6 weeks.

Control groupEMT groupIMT & EMT

5 sets, 5 repetition with one or two minute of rest between sets, twice per day, 5 days per week, training with breathing trainer.

EMT group

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients identified as stroke and capable of performing voluntary respiratory maneuvers.

You may not qualify if:

  • Increased intracranial pressure
  • Uncontrolled hypertension
  • Complicated arrhythmia
  • Decompensated heart failure
  • Unstable angina
  • Myocardial infarction in the preceding 3 months
  • Pneumothorax, bullae/blebs or infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital.

Kaohsiung City, 83305, Taiwan

Location

Related Publications (1)

  • Liaw MY, Hsu CH, Leong CP, Liao CY, Wang LY, Lu CH, Lin MC. Respiratory muscle training in stroke patients with respiratory muscle weakness, dysphagia, and dysarthria - a prospective randomized trial. Medicine (Baltimore). 2020 Mar;99(10):e19337. doi: 10.1097/MD.0000000000019337.

MeSH Terms

Conditions

Cerebrovascular Disorders

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Liaw Mei-Yun, MD

    Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor in Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

January 30, 2018

First Posted

April 9, 2018

Study Start

April 1, 2016

Primary Completion

July 18, 2018

Study Completion

July 31, 2018

Last Updated

December 1, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations